Literature DB >> 17348457

Systematic development of clinical practice guidelines for prostate biopsies: a 3-year Italian project.

Alessandro Bertaccini1, Andrea Fandella, Tommaso Prayer-Galetti, Vincenzo Scattoni, Andrea B Galosi, Vincenzo Ficarra, Carlo Trombetta, Massimo Gion, Giuseppe Martorana.   

Abstract

BACKGROUND: The only available method to detect prostate cancer is prostate biopsy; however, to our knowledge, no evidence-based clinical practice guidelines have been established on this topic.
MATERIALS AND METHODS: A three-year project was elaborated in which experts in the field worked to define the controversies existing in clinical practice regarding prostatic biopsies and then to develop guidelines by means of a systematic search of all the English-language literature using online databases and a consensus conference. RESULTS AND
CONCLUSION: The guidelines were formulated to help practitioners in making clinical decisions regarding the appropriate time the patient should undergo prostate biopsy, the type of antibiotic prophylaxis and anaesthesia, the biopsy approach, the method for processing and reporting prostatic needle cores, the biopsy technique, when to repeat a biopsy after a prior negative biopsy, radiotherapy or radical prostatectomy and the accuracy of biopsies in staging prostate cancer.

Entities:  

Mesh:

Year:  2007        PMID: 17348457

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  Minimum 6 mm core length is strongly predictive for the presence of glandular tissue in transrectal prostate biopsy.

Authors:  Hasan Yilmaz; Seyfettin Ciftci; Murat Ustuner; Ufuk Yavuz; Ali Saribacak; Bahar Muezzinoglu; Ozdal Dillioglugil
Journal:  World J Urol       Date:  2015-03-17       Impact factor: 4.226

2.  Do longer or shorter cores yield more cancer?

Authors:  Yılmaz Hasan; Dillioğlugil Özdal
Journal:  World J Urol       Date:  2018-04-27       Impact factor: 4.226

3.  Are 10-, 10-12-, or > 12-mm prostate biopsy core quality control cutoffs reasonable?

Authors:  Brunno C F Sanches; Ana Luiza Lalli; Wilmar Azal Neto; Athanase Billis; Leonardo Oliveira Reis
Journal:  World J Urol       Date:  2018-03-01       Impact factor: 4.226

4.  Longer biopsy cores do not increase prostate cancer detection rate: A large-scale cohort study refuting cut-off values indicated in the literature.

Authors:  Hasan Yılmaz; Ufuk Yavuz; Murat Üstüner; Seyfettin Çiftçi; Hikmet Yaşar; Bahar Müezzinoğlu; Ali Kemal Uslubaş; Özdal Dillioğlugil
Journal:  Turk J Urol       Date:  2017-07-31

Review 5.  Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing.

Authors:  Marc A Bjurlin; H Ballentine Carter; Paul Schellhammer; Michael S Cookson; Leonard G Gomella; Dean Troyer; Thomas M Wheeler; Steven Schlossberg; David F Penson; Samir S Taneja
Journal:  J Urol       Date:  2013-02-26       Impact factor: 7.450

6.  Guidelines on processing and reporting of prostate biopsies: the 2013 update of the pathology committee of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Authors:  T Van der Kwast; L Bubendorf; C Mazerolles; M R Raspollini; G J Van Leenders; C-G Pihl; P Kujala
Journal:  Virchows Arch       Date:  2013-08-06       Impact factor: 4.064

7.  Specimen orientation by marking the peripheral end: (potential) clinical advantages in prostate biopsy.

Authors:  Andrea Benedetto Galosi; Giovanni Muzzonigro; Vito Lacetera; Roberta Mazzucchelli
Journal:  Prostate Cancer       Date:  2011-07-27

8.  Length of prostate biopsies is not necessarily compromised by pooling multiple cores in one paraffin block: an observational study.

Authors:  Teemu T Tolonen; Jorma Isola; Antti Kaipia; Jarno Riikonen; Laura Koivusalo; Sanna Huovinen; Marita Laurila; Sinikka Porre; Mika Tirkkonen; Paula Kujala
Journal:  BMC Clin Pathol       Date:  2015-03-08

9.  Is Prostate Biopsy Recommended in Turkish Men with a Prostate-Specific Antigen Level between 2.5 and 4 ng/mL?

Authors:  Gokhan Koc; Hakan Turk; Mustafa Karabicak; Sitki Un; Batuhan Ergani; Rahmi Gokhan Ekin
Journal:  Curr Ther Res Clin Exp       Date:  2017-04-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.